Journal
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY
Volume 50, Issue 1, Pages 198-207Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/21691401.2022.2092123
Keywords
Glioblastoma; microRNA; Chitosan; Nanoparticles; gene delivery; microRNA-219
Categories
Funding
- King Saud University, Riyadh, Saudi Arabia [RSP-2022R423]
Ask authors/readers for more resources
The use of miR-219 nanoparticles shows potential for the treatment of glioblastoma, as they have been found to induce apoptosis in GBM cells.
Recent evidence has implicated microRNA-219 (miR-219) in regulation of gene contributed in glioblastoma (GBM) pathogenesis. This study aimed to prepare miR-219 in chitosan (CS) nanoparticles (NPs), characterize and investigate their efficacy on human GBM cell line (U87 MG). NPs were prepared using ionic gelation method. The influence of process parameters on physicochemical characteristics of NPs was investigated. Apoptotic effect of miR-219 was examined on U87 MG cells. Formulated NPs showed particle size of 109 +/- 2.18 nm, with poly dispersity index equal to 0.2 +/- 0.05, and zeta potential of +20.5 +/- 0.7 mV. Entrapment efficiency of miR-219 in loaded NP has reached 95%. The in vitro release study demonstrated sustained release pattern of miR-219 from CS-NPs. Gel retardation assay has confirmed the integrity of miR-219 after production process. The fabricated NPs reduced the survival of U87 MG cells to 78% after 24 h of post-transfection, and into 67.5% after 48 h. However, fibroblasts were not affected by the NPs, revealing their specificity for GBM cells. Given the tumour suppressing function of miR-219, and advantage of CS-NPs for gene delivery to the central nervous system, the presented NPs have a great potential for treatment of GBM.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available